{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T02:07:44Z","timestamp":1776305264752,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T00:00:00Z","timestamp":1710547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.abd.2023.07.006","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T22:58:13Z","timestamp":1712962693000},"page":"632-634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Secondary syphilis occurring under anti-CD20 therapy: risks, progression and approach"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8471-7903","authenticated-orcid":false,"given":"Luiz Augusto Fabricio de Melo","family":"Garbers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4450-4898","authenticated-orcid":false,"given":"Tissiana Marques de","family":"Haes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8157-7658","authenticated-orcid":false,"given":"Cacilda da","family":"Silva Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2023.07.006_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578066","article-title":"Predictors of hypogammaglobulinemia and serious infections among patients receiving ocrelizumab or rituximab for treatment of MS and NMOSD","volume":"377","author":"Mears","year":"2023","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.abd.2023.07.006_bib0010","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1111\/jdv.17126","article-title":"Serological diagnosis of secondary syphilis in a Rituximab-treated patient: an emerging diagnostic challenge?","volume":"35","author":"Lefeuvre","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.abd.2023.07.006_bib0015","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1016\/j.reuma.2017.12.008","article-title":"Syphilis in the setting of anti-tumor necrosis factor alpha therapy","volume":"15","author":"Iglesias-Plaza","year":"2019","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"10.1016\/j.abd.2023.07.006_bib0020","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1111\/ijd.13389","article-title":"Re-emergence of syphilis in the biological era","volume":"55","author":"Pedrosa","year":"2016","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2023.07.006_bib0025","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/ced.13189","article-title":"Secondary syphilis infection under treatment with ustekinumab","volume":"42","author":"Uslu","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.abd.2023.07.006_bib0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.diagmicrobio.2019.04.009","article-title":"A rare case of malignant syphilis after adalimumab therapy due to Crohn\u2019s disease associated with bariatric surgery","volume":"95","author":"Y\u0131ld\u0131zhan","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.abd.2023.07.006_bib0035","doi-asserted-by":"crossref","first-page":"S382","DOI":"10.1097\/RHU.0000000000001495","article-title":"Malignant syphilis in a young patient with juvenile idiopathic arthritis under biological therapy","volume":"27","author":"Dos Santos","year":"2021","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.abd.2023.07.006_bib0040","article-title":"The great imitator: latent neurosyphilis revealed after initiation of the immunosuppressive drug secukinumab","volume":"13","author":"Duncan","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.abd.2023.07.006_bib0045","unstructured":"Centers for disease control and prevention. Sexually transmitted infections treatment guidelines, 2021. Division of STD prevention, national center for HIV, Viral Hepatitis, STD, and TB prevention, centers for disease control and prevention. [Cited 28 June 2023] Available from: https:\/\/www.cdc.gov\/std\/treatment-guidelines\/syphilis.htm."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059624000412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059624000412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:51Z","timestamp":1747666851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059624000412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0365059624000412"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2023.07.006","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary syphilis occurring under anti-CD20 therapy: risks, progression and approach","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2023.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}